Answers are grounded in this paper and cite their sources.
Tacrolimus-based therapy resulted in significantly reduced risk of graft failure, without an increase in the incidence of adverse events associated with long-term immunosuppression.
No takes yet. Share an insight, caveat, or question.
Vincenti et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: